| Citation: |
CHEN Meiping, YANG Hongbo, PAN Hui, FENG Feng, ZHU Yicheng, ZHU Huijuan. Clinical Features and Mutation Analysis of Gordon Holmes Syndrome Associated with RNF216 Gene Mutation and a Literature Review[J]. Journal of Rare Diseases, 2023, 2(3): 337-345. DOI: 10.12376/j.issn.2097-0501.2023.03.004
|
To summarize the clinical characteristics and RNF216 gene mutation of a patient with Gordon Holmes syndrome (GHS), and to improve the understanding of the genetic and clinica characteristics of this disease through literature review.
We collected the clinical data of the patient with GHS, extracted the DNA from 2 mL peripheral venous blood of the patient and his parents for whole exome gene detection, and then we analyzed the clinical and genetic characteristics of all previously reported patients with RNF216 gene mutation.
The young male patient was short in stature at sixyearsold and was diagnosed growth hormone deficiency.He had no secondary sexual characteristics by the age of 15 and was diagnosed hypogonadal hypogonadism.After the age of 22, he gradually developed abnormal gait and had progressive decline in speech, motor, and cognitive functions.Whole exome sequencing revealed a homozygous, nonsense mutation c.1549C>T (p.R517*) in the RNF216 gene.His parents were consanguineous and were heterozygous carriers of the mutations with phenotypic normality.Combined with literature review and this case report results showed that a total of 21 patients of the disease in the world and among them 15 had pathogenic variants of RNF216 gene mutation.7 of the 15 had truncated mutations, 5 had missense mutations, and 1 synonym mutation, 1 splice mutation, and 1 deletion mutation respectively.RNF216 gene mutation can be seen in neurodegenerative diseases with multiple overlapping symptoms of GHS, Huntington-like disease, and 4H syndrome.The main clinical manifestations are hypogonadotropic hypogonadism and early-onset progressive neurological dysfunction in adolescence or early adulthood.The median age of onset of neurological symptoms is 28 years old, featuring cerebellar ataxia, dysarthria, and cognitive impairment, as well as imaging manifestations of extensive white matter lesions and cerebellar atrophy.
The mutation of RNF216 gene can cause GHS.Genetic testing is helpful to the diagnosis and treatment of rare diseases.
| [1] |
Samuel M, Torun N, Tuite PJ, et al. Progressive ataxia and palatal tremor(PAPT): clinical and MRI assessment with review of palatal tremors[J]. Brain, 2004, 127(Pt 6): 1252-1268.
|
| [2] |
Margolin DH, Kousi M, Chan YM, et al. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination[J]. N Engl J Med, 2013, 368(21): 1992-2003. doi: 10.1056/NEJMoa1215993
|
| [3] |
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform[J]. Bioinformatics, 2009, 25(14): 1754-1760. doi: 10.1093/bioinformatics/btp324
|
| [4] |
Ganos C, Hersheson J, Adams M, et al. The 4H syndrome due to RNF216 mutation[J]. Parkinsonism Relat Disord, 2015, 21(9): 1122-1123. doi: 10.1016/j.parkreldis.2015.07.012
|
| [5] |
Alqwaifly M, Bohlega S. Ataxia and hypogonadotropic hypogonadism with intrafamilial variability caused by RNF216 mutation[J]. Neurol Int, 2016, 8(2): 6444.
|
| [6] |
Santens P, Van Damme T, Steyaert W, et al. RNF216 mutations as a novel cause of autosomal recessive Huntington-like disorder[J]. Neurology, 2015, 84(17): 1760-1766. doi: 10.1212/WNL.0000000000001521
|
| [7] |
Calandra CR, Mocarbel Y, Vishnopolska SA, et al. Gordon Holmes syndrome caused by rnf216 novel mutation in 2 argentinean siblings[J]. Mov Disord Clin Pract, 2019, 6(3): 259-262. doi: 10.1002/mdc3.12721
|
| [8] |
Chen KL, Zhao GX, Wang H, et al. A novel de novo RNF216 mutation associated with autosomal recessive Huntington-like disorder[J]. Ann Clin Transl Neurol, 2020, 7(5): 860-864. doi: 10.1002/acn3.51047
|
| [9] |
Chen KL, Wang H, Zhao GX, et al. Whole-exome sequencing identified a novel mutation in rnf216 in a family with gordon holmes syndrome[J]. J Mol Neurosci, 2022, 72(4): 691-694. doi: 10.1007/s12031-021-01953-0
|
| [10] |
Hershko A, Ciechanover A. The ubiquitin system[J]. Annu Rev Biochem, 1998, 67: 425-479. doi: 10.1146/annurev.biochem.67.1.425
|
| [11] |
Komander D, Rape M. The ubiquitin code[J]. Annu Rev Biochem, 2012, 81: 203-229. doi: 10.1146/annurev-biochem-060310-170328
|
| [12] |
Alturki NA, McComb S, Ariana A, et al. Triad3a induces the degradation of early necrosome to limit RipK1-dependent cytokine production and necroptosis[J]. Cell Death Dis, 2018, 9(6): 592. doi: 10.1038/s41419-018-0672-0
|
| [13] |
Kim YH, Kwak MS, Shin JM, et al. Inflachromene inhibits autophagy through modulation of Beclin 1 activity[J]. J Cell Sci, 2018, 131(4): jcs211201.
|
| [14] |
Cotton TR, Cobbold SA, Bernardini JP, et al. Structural basis of K63-ubiquitin chain formation by the Gordon-Holmes syndrome RBR E3 ubiquitin ligase RNF216[J]. Mol Cell, 2022, 82(3): 598-615. e8. doi: 10.1016/j.molcel.2021.12.005
|
| [15] |
Mabb AM, Je HS, Wall MJ, et al. Triad3A regulates synaptic strength by ubiquitination of Arc[J]. Neuron, 2014, 82(6): 1299-1316. doi: 10.1016/j.neuron.2014.05.016
|
| [16] |
Aycan Z, Savaş-Erdeve Ş, Çetinkaya S, et al. Investiga-tion of MKRN3 mutation in patients with familial central precocious puberty[J]. J Clin Res Pediatr Endocrinol, 2018, 10(3): 223-229. doi: 10.4274/jcrpe.5506
|
| [17] |
Hayer SN, Deconinck T, Bender B, et al. STUB1/CHIP mutations cause Gordon Holmes syndrome as part of a widespread multisystemic neurodegeneration: evidence from four novel mutations[J]. Orphanet J Rare Dis, 2017, 12(1): 31. doi: 10.1186/s13023-017-0580-x
|
| [18] |
Melnick AF, Gao Y, Liu J, et al. RNF216 is essential for spermatogenesis and male fertility[J]. Biol Reprod, 2019, 100(5): 1132-1134. doi: 10.1093/biolre/ioz006
|
| [19] |
Li D, Li F, Meng L, et al. RNF216 regulates meiosis and PKA stability in the testes[J]. FASEB J, 2021, 35(4): e21460.
|
| [1] | XU Yiming, PENG Huiming, LYU Shuaijie, TONG Peijian, LI Hu, CHEN Fenyong, WANG Haibin, YANG Qi, CHEN Bin, YUAN Zhen, BI Rongxiu, FENG Jianmin, JIANG Wenxue, ZHOU Zongke, FAN Meng, LI Xiang, LEI Guanghua, WENG Xisheng. A Survey of the Current Status of Surgical Treatment of Hemophilic Osteoarthropathy in China Mainland 17 Grade A General Hospitals[J]. Journal of Rare Diseases, 2023, 2(4): 516-522. DOI: 10.12376/j.issn.2097-0501.2023.04.008 |
| [2] | YE Changxiong, SUN Jing. Development and Utilization of "One-Stop Finance Service" forRelief Fund for Hemophilia Patients[J]. Journal of Rare Diseases, 2022, 1(4): 474-478. DOI: 10.12376/j.issn.2097-0501.2022.04.019 |
| [3] | LI Shunping, DOU Lei, FANG Yunhai. Current Situation and Prospect of Pharmacoeconomic Evaluation of Hemophilia in China[J]. Journal of Rare Diseases, 2022, 1(4): 468-473. DOI: 10.12376/j.issn.2097-0501.2022.04.018 |
| [4] | ZHANG Jing, JU Mankai, ZHANG Kemin, CHEN Lingling, WANG Yuhua, ZHANG Lei, YANG Renchi, XUE Feng. A Case of Hemophilia B with Abdominal and Pelvic Pseudotumor[J]. Journal of Rare Diseases, 2022, 1(4): 456-460. DOI: 10.12376/j.issn.2097-0501.2022.04.016 |
| [5] | GUO Xinjuan, DING Xiaoling, LI Dongshuang, LI Jun. Practical Guidance for Ultrasonic Evaluation of Hemophilic Arthropathy[J]. Journal of Rare Diseases, 2022, 1(4): 449-455. DOI: 10.12376/j.issn.2097-0501.2022.04.015 |
| [6] | Hemophilia Treatment Center Collaborative Network of China. Chinese Expert Consensus on Pharmacokinetics Guided Treatment for Hemophilia A[J]. Journal of Rare Diseases, 2022, 1(4): 428-434. DOI: 10.12376/j.issn.2097-0501.2022.04.011 |
| [7] | DAI Xinyue, ZHANG Lei. Status and Prospect of Gene Therapy for Hemophilia[J]. Journal of Rare Diseases, 2022, 1(4): 386-390. DOI: 10.12376/j.issn.2097-0501.2022.04.005 |
| [8] | CHENG Yan, FANG Yunhai, ZHANG Xinsheng. Current Status and Discussion of Hemophilia Aid System[J]. Journal of Rare Diseases, 2022, 1(4): 375-379. DOI: 10.12376/j.issn.2097-0501.2022.04.003 |
| [9] | XUE Feng, YANG Renchi. Establishment and Evolution of China National Hemophilia Registry[J]. Journal of Rare Diseases, 2022, 1(4): 370-374. DOI: 10.12376/j.issn.2097-0501.2022.04.002 |
| [10] | YANG Renchi. Establishment of Care System for Hemophilia in China: Current Status and Future Prospect[J]. Journal of Rare Diseases, 2022, 1(4): 365-369. DOI: 10.12376/j.issn.2097-0501.2022.04.001 |
Official account
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Author
Peer Review
Editorial Entry
Editor Work
DownLoad: